- cafead   Aug 03, 2021 at 11:22: AM
via The U.S. Food and Drug Administration (FDA) has approved the continued development of a new oral tablet SARS-CoV-2 vaccine candidate. The drug, created by Vaxart, completed its Phase I trial and has submitted an Investigational New Drug application to move forward.
article source
article source